Impact of Clinical Use of Probiotics on Preterm-Related Outcomes in Infants with Extremely Low Birth Weight
- PMID: 39275310
- PMCID: PMC11397160
- DOI: 10.3390/nu16172995
Impact of Clinical Use of Probiotics on Preterm-Related Outcomes in Infants with Extremely Low Birth Weight
Abstract
Background: Preterm birth significantly contributes to mortality and morbidities, with recent studies linking these issues to gut microbiota imbalances. Probiotic supplementation shows promise in mitigating adverse outcomes in preterm infants, but optimal timing and guidelines remain unclear. This study assesses the benefits of probiotic supplementation for preterm infants without consistent guidelines. Methods: This retrospective study examined extremely low-birth-weight (ELBW) infants in neonatal intensive care units from 2017 to 2021. Mortality and preterm-related outcomes were compared between infants receiving probiotics and those not. Subgroup analyses based on probiotic initiation timing were conducted: early (≤14 days), late (>14 days), and non-probiotic groups. Results: The study included 330 ELBW infants: 206 received probiotics (60 early, 146 late), while 124 did not. Probiotic supplementation was associated with lower overall mortality (adjusted OR 0.22, 95% CI 0.09-0.48) and decreased mortality from necrotizing enterocolitis (NEC) or late-onset sepsis (LOS) (adjusted OR 0.12, 95% CI 0.03-0.45). Early probiotics reduced overall mortality, NEC/LOS-related mortality, and NEC/LOS-unrelated mortality. Late probiotics decreased overall mortality and NEC/LOS-related mortality. Early probiotic use also expedited full enteral feeding achievement. Conclusions: Probiotic supplementation reduces mortality and improves feeding tolerance in preterm infants. Establishing guidelines for probiotic use in this population is crucial.
Keywords: extremely low birth weight; mortality; probiotics.
Conflict of interest statement
The authors that there are no conflicts of interest associated with this research.
Figures


Similar articles
-
Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2018 Dec 12;12(12):CD012519. doi: 10.1002/14651858.CD012519.pub2. Cochrane Database Syst Rev. 2018. PMID: 30548483 Free PMC article.
-
Probiotics for prevention of necrotizing enterocolitis in preterm infants.Evid Based Child Health. 2014 Sep;9(3):584-671. doi: 10.1002/ebch.1976. Evid Based Child Health. 2014. PMID: 25236307 Review.
-
Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.Cochrane Database Syst Rev. 2020 Oct 15;10(10):CD005496. doi: 10.1002/14651858.CD005496.pub5. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2023 Jul 26;7:CD005496. doi: 10.1002/14651858.CD005496.pub6. PMID: 33058137 Free PMC article. Updated.
-
Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin.J Neonatal Perinatal Med. 2017;10(3):249-255. doi: 10.3233/NPM-16130. J Neonatal Perinatal Med. 2017. PMID: 28854514
-
A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.Health Technol Assess. 2016 Aug;20(66):1-194. doi: 10.3310/hta20660. Health Technol Assess. 2016. PMID: 27594381 Free PMC article. Clinical Trial.
References
-
- Liu L., Oza S., Hogan D., Chu Y., Perin J., Zhu J., Lawn J.E., Cousens S., Mathers C., Black R.E. Global, regional, and national causes of under-5 mortality in 2000-15: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027–3035. doi: 10.1016/S0140-6736(16)31593-8. - DOI - PMC - PubMed
-
- Bell E.F., Hintz S.R., Hansen N.I., Bann C.M., Wyckoff M.H., DeMauro S.B., Walsh M.C., Vohr B.R., Stoll B.J., Carlo W.A., et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013–2018. JAMA. 2022;327:248–263. doi: 10.1001/jama.2021.23580. - DOI - PMC - PubMed
-
- Staude B., Oehmke F., Lauer T., Behnke J., Göpel W., Schloter M., Schulz H., Krauss-Etschmann S., Ehrhardt H. The Microbiome and Preterm Birth: A Change in Paradigm with Profound Implications for Pathophysiologic Concepts and Novel Therapeutic Strategies. Biomed. Res. Int. 2018;2018:7218187. doi: 10.1155/2018/7218187. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical